<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01739699</url>
  </required_header>
  <id_info>
    <org_study_id>EH11-380</org_study_id>
    <nct_id>NCT01739699</nct_id>
  </id_info>
  <brief_title>The Efficacy of Intravenous Acetaminophen During Perioperative Neurosurgery Period</brief_title>
  <official_title>The Efficacy of Intravenous Acetaminophen During The Perioperative Period Of Neurosurgical Patients Undergoing Craniotomies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NorthShore University HealthSystem</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cadence Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>NorthShore University HealthSystem</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective randomized double blinded trial study involving 128 patients undergoing&#xD;
      any craniotomy procedure at Evanston Hospital. The patients will be randomized by the sealed&#xD;
      envelope technique. The anesthesiologist and nurses who will be administering the placebo or&#xD;
      intravenous acetaminophen will be blinded to the group in which patients are assigned.&#xD;
&#xD;
      The following general perioperative data will be recorded: patient information/preoperative&#xD;
      data, procedural information, postoperative information, and overall satisfaction of pain&#xD;
      management at 24 hours after surgery.&#xD;
&#xD;
      Based on a pilot study (N-20) we expect that 25% of the placebo treated patients will require&#xD;
      no opioids in the first 24 hour postoperative period. With the use of intravenous&#xD;
      acetaminophen, it is hypothesized that the number of patients that do not require opioids in&#xD;
      the first 24 hours after surgery will double.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective randomized double blinded trial study involving 128 patients undergoing&#xD;
      any craniotomy procedure at Evanston Hospital. The patients will be randomized by the sealed&#xD;
      envelope technique. The anesthesiologist and nurses who will be administering the placebo or&#xD;
      intravenous acetaminophen will be blinded to the group in which patients are assigned.&#xD;
&#xD;
      The following information will be recorded for each patient enrolled in this study:&#xD;
&#xD;
        -  Patient information/Preoperative Data&#xD;
&#xD;
             -  Age, sex, height, weight,&#xD;
&#xD;
             -  Disease specific information&#xD;
&#xD;
             -  Primary diagnosis&#xD;
&#xD;
             -  Pertinent medical history&#xD;
&#xD;
             -  Medications&#xD;
&#xD;
             -  Pertinent changes in patient status&#xD;
&#xD;
        -  Procedural information&#xD;
&#xD;
             -  Operation type&#xD;
&#xD;
             -  Preoperative anesthetic medications&#xD;
&#xD;
             -  Induction meds, intra-operative anesthetic meds, and post-operative anesthetic meds&#xD;
&#xD;
             -  Duration of Surgery and Intubation&#xD;
&#xD;
             -  Amount of dilaudid equivalent narcotics&#xD;
&#xD;
        -  Postoperative Information&#xD;
&#xD;
             -  Amount of narcotics administered in the PACU&#xD;
&#xD;
             -  Amount of narcotics administered in the first 24 hour postoperative period&#xD;
&#xD;
             -  Amount of non-narcotic analgesics administered in the first 24 hour postoperative&#xD;
                period&#xD;
&#xD;
             -  Time to first rescue analgesic in the PACU&#xD;
&#xD;
             -  Amount of first rescue medication recorded&#xD;
&#xD;
             -  Assessment of Pain Intensity at T0.5 (30min into PACU stay) and T24 (24 hours after&#xD;
                end of surgery) (A 10-cm VAS scale will be used and labeled no pain at its left&#xD;
                terminus and worst pain imaginable at its right terminus)&#xD;
&#xD;
             -  Temperature in degrees centigrade every 8 hours for 24hours.&#xD;
&#xD;
             -  CAM-ICU is performed by ICU nurses to detect delirium in patients every 8 hours and&#xD;
                will be documented on a data collection sheet for the first 24 hours&#xD;
&#xD;
             -  RASS is a sedation scoring system that is used in our ICU and is documented every 8&#xD;
                hours by ICU nursing. We will record the RASS score for the first 24 hours on a&#xD;
                data collection sheet as documented by the ICU nurse.&#xD;
&#xD;
             -  Overall satisfaction score at 24 hrs. &quot;Overall satisfaction with pain management&quot;&#xD;
                (verbal rating score: scale 1 - 100)&#xD;
&#xD;
      Based on a pilot study (N-20) we expect that 25% of the placebo treated patients will require&#xD;
      no opioids in the first 24 hour postoperative period. With the use of intravenous&#xD;
      acetaminophen, it is hypothesized that the number of patients that do not require opioids in&#xD;
      the first 24 hours after surgery will double.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">January 20, 2017</completion_date>
  <primary_completion_date type="Actual">August 1, 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid Requirement After Surgery</measure>
    <time_frame>during first 24 hours after surgery</time_frame>
    <description>The purpose of the study was to determine whether more patients undergoing craniotomies would not require any opioids (i.e., opioid consumption reduced to zero) during the first 24 postoperative hours when receiving intravenous (IV) acetaminophen during that time compared to those receiving placebo (normal saline).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Rescue Medication in Both Groups</measure>
    <time_frame>0 to 24 hours after surgery</time_frame>
    <description>Time (minutes) from end of procedure to first rescue dose in either PACU or ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of Rescue Medication in PACU in Both Groups</measure>
    <time_frame>0 to 24 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median Difference in ICU Length of Stay/Hospital Length of Stay Between Both Groups</measure>
    <time_frame>from 0 to estimated 24 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Had a Successful Neurologic Exams Between Intervention and Placebo Group as Determined by a Neurosurgical Provider by Answering Either Yes or No</measure>
    <time_frame>from 0 to estimated maximum of 24 hours after surgery</time_frame>
    <description>Successful neurologic exams are performed by neurosurgical team during the first 24 hour period. Successful neurologic exams will be provided by a neurosurgical professional and they will answer Yes or No if the exam is appropriate.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median Difference in Temperature Between Intervention and Placebo Groups</measure>
    <time_frame>from 0 to estimated maximum 24 hours after surgery</time_frame>
    <description>Temperature measure in degrees celcius during the first 24hours postoperatively in increments of 8 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation Scores Measured by Richmand-Agitation-Sedation Scale (RASS) Every 8 Hours for 24 Hours in Both Groups</measure>
    <time_frame>during first 24 hours after surgery</time_frame>
    <description>Sedation scores will be evaluated by providers through the Richmand-Agitation-Sedation Scale (RASS) system every 8 hours for the first 24hour postoperatively. The RASS is a 10 point scale with four levels for anxiety or agitation (+1 to +4 (indicates more agitation and alertness the higher number you have)), one level to indicate a calm and alert state (0), and 5 levels of deeper sedation (-1 to -5 ( the more negative number indicating a deeper level of sedation)) patients. It helps guide sedation therapy at the bedside. There are no worse outcomes with different levels of sedation scores. However, typically, we try to keep the scores in the range of 0-+1 to be able to appropriately assess patients and allow them to be mobile in a safe fashion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain VAS Scores (1-100) Every 8 Hours for 24 Hours in Both Groups</measure>
    <time_frame>during first 24 hours after surgery</time_frame>
    <description>Pain was measured using the Visual Analog Scale (VAS) for each patient at the time of arrival and every eight hours after arrival for the first 24 hours of ICU stay. A VAS score of 1 indicates little or no pain and a VAS score of 100 indicates severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure># of Participants With Delirium Measured by a Positive CAM-ICU Every 8 Hours for 24 Hours in Both Groups-</measure>
    <time_frame>during first 24 hours after surgery</time_frame>
    <description>Delirium was assessed in each of the participants upon arrival to the ICU using the Confusion Assessment Method for the ICU (CAM-ICU). The CAM-ICU was performed for each participant every 8 hours following admission for the first 24 hours&#xD;
The CAM ICU scoring is based on a scale of 0-7, 0-2=no delirium, 3-5=miild delirium, 6-7=severe delirium. The positive CAM ICU consists of features 1 and 2 and either 3 or 4:&#xD;
Features 1: Acute onset or fluctuating course Features 2: Inattention Features 3: Disorganized thinking Features 4: Altered level of consciousness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median Satisfaction Scores on a Verbal Score From 1(Not Satisfied at All) to 100 (Very Satisfied)</measure>
    <time_frame>During first 24 hours after surgery</time_frame>
    <description>on a verbal score 1-100, 1 would mean that the patient is not satisfied at all and 100 would mean that the patient was very satisfied.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Craniotomy</condition>
  <condition>Brain Surgery</condition>
  <arm_group>
    <arm_group_label>Acetaminophen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive 1000mg of intravenous acetaminophen every 6 hours for 24 hours beginning with dural closure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects will receive 100cc of normal saline every 6 hours for 24 hours beginning at dural closure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <arm_group_label>Acetaminophen</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject are able to provide informed consent prior to participation in the study&#xD;
&#xD;
          -  Subjects must be scheduled to undergo elective open craniotomy procedure of &gt; 2 hour&#xD;
             duration&#xD;
&#xD;
          -  Subjects must be &gt;18 years old but less than 90 years old&#xD;
&#xD;
          -  Subjects must have an American Society of Anesthesiologists (ASA) class I-IV&#xD;
&#xD;
          -  Subjects must have the ability to communicate meaningfully with the investigator staff&#xD;
             and read/understand the study procedures and the use of pain scales&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects used opioids or tramadol daily for &gt;7 days before study medication&#xD;
             administration&#xD;
&#xD;
          -  Subjects had been treated with any of the following within 14 days of surgery:&#xD;
             chaparral, comfrey, germander, jin bu huan, kava, pennyroyal, skullcap, St. John's&#xD;
             wort, or valerian&#xD;
&#xD;
          -  Subjects who have a chronic pain condition, significant medical disease or laboratory&#xD;
             abnormality that in the investigator's judgment could compromise the subject's welfare&#xD;
&#xD;
          -  Subjects with known hypersensitivity to opioids, acetaminophen or the inactive&#xD;
             ingredients&#xD;
&#xD;
          -  Subjects with known or suspected history of alcohol or drug abuse or dependence in the&#xD;
             previous 2 years prior to the proposed surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Greenberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NorthShore University Health Sytem - Evanston Hospital Department of Anesthesia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NorthShore University HealthSystem</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>November 28, 2012</study_first_submitted>
  <study_first_submitted_qc>November 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2012</study_first_posted>
  <results_first_submitted>February 16, 2017</results_first_submitted>
  <results_first_submitted_qc>October 7, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">November 4, 2021</results_first_posted>
  <last_update_submitted>October 7, 2021</last_update_submitted>
  <last_update_submitted_qc>October 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>NorthShore University HealthSystem</investigator_affiliation>
    <investigator_full_name>Steven Greenberg</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>craniotomy</keyword>
  <keyword>brain surgery</keyword>
  <keyword>acetaminophen</keyword>
  <keyword>Tylenol</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data is stored in file at our system</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>anytime</ipd_time_frame>
    <ipd_access_criteria>anytime</ipd_access_criteria>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Acetaminophen</title>
          <description>Subjects will receive 1000mg of intravenous acetaminophen every 6 hours for 24 hours beginning with dural closure.&#xD;
Acetaminophen</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Subjects will receive 100cc of normal saline every 6 hours for 24 hours beginning at dural closure.&#xD;
Placebo</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="70"/>
                <participants group_id="P2" count="70"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
                <participants group_id="P2" count="65"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Acetaminophen</title>
          <description>Subjects will receive 1000mg of intravenous acetaminophen every 6 hours for 24 hours beginning with dural closure.&#xD;
Acetaminophen</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Subjects will receive 100cc of normal saline every 6 hours for 24 hours beginning at dural closure.&#xD;
Placebo</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="70"/>
            <count group_id="B2" value="70"/>
            <count group_id="B3" value="140"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="70"/>
                    <count group_id="B2" value="70"/>
                    <count group_id="B3" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="91"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="70"/>
                    <count group_id="B2" value="70"/>
                    <count group_id="B3" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58" spread="15"/>
                    <measurement group_id="B2" value="56" spread="13"/>
                    <measurement group_id="B3" value="57" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="70"/>
                    <count group_id="B2" value="70"/>
                    <count group_id="B3" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="77"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="70"/>
                    <count group_id="B2" value="70"/>
                    <count group_id="B3" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                    <measurement group_id="B2" value="70"/>
                    <measurement group_id="B3" value="140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Opioid Requirement After Surgery</title>
        <description>The purpose of the study was to determine whether more patients undergoing craniotomies would not require any opioids (i.e., opioid consumption reduced to zero) during the first 24 postoperative hours when receiving intravenous (IV) acetaminophen during that time compared to those receiving placebo (normal saline).</description>
        <time_frame>during first 24 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>Subjects will receive 1000mg of intravenous acetaminophen every 6 hours for 24 hours beginning with dural closure.&#xD;
Acetaminophen</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects will receive 100cc of normal saline every 6 hours for 24 hours beginning at dural closure.&#xD;
Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Requirement After Surgery</title>
          <description>The purpose of the study was to determine whether more patients undergoing craniotomies would not require any opioids (i.e., opioid consumption reduced to zero) during the first 24 postoperative hours when receiving intravenous (IV) acetaminophen during that time compared to those receiving placebo (normal saline).</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Rescue Medication in Both Groups</title>
        <description>Time (minutes) from end of procedure to first rescue dose in either PACU or ICU</description>
        <time_frame>0 to 24 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>Subjects will receive 1000mg of intravenous acetaminophen every 6 hours for 24 hours beginning with dural closure.&#xD;
Acetaminophen</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects will receive 100cc of normal saline every 6 hours for 24 hours beginning at dural closure.&#xD;
Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Rescue Medication in Both Groups</title>
          <description>Time (minutes) from end of procedure to first rescue dose in either PACU or ICU</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22" lower_limit="16.5" upper_limit="33"/>
                    <measurement group_id="O2" value="37" lower_limit="20.5" upper_limit="53.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Amount of Rescue Medication in PACU in Both Groups</title>
        <time_frame>0 to 24 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>Subjects will receive 1000mg of intravenous acetaminophen every 6 hours for 24 hours beginning with dural closure.&#xD;
Acetaminophen</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects will receive 100cc of normal saline every 6 hours for 24 hours beginning at dural closure.&#xD;
Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Amount of Rescue Medication in PACU in Both Groups</title>
          <units>mg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" lower_limit="0.3" upper_limit="0.5"/>
                    <measurement group_id="O2" value="0.5" lower_limit="0.3" upper_limit="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Median Difference in ICU Length of Stay/Hospital Length of Stay Between Both Groups</title>
        <time_frame>from 0 to estimated 24 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>Subjects will receive 1000mg of intravenous acetaminophen every 6 hours for 24 hours beginning with dural closure.&#xD;
Acetaminophen</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects will receive 100cc of normal saline every 6 hours for 24 hours beginning at dural closure.&#xD;
Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Median Difference in ICU Length of Stay/Hospital Length of Stay Between Both Groups</title>
          <units>hours</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hospital Length of stay</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.75" lower_limit="49" upper_limit="118"/>
                    <measurement group_id="O2" value="75.5" lower_limit="50" upper_limit="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ICU length of stay</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26" lower_limit="21.5" upper_limit="41"/>
                    <measurement group_id="O2" value="28" lower_limit="22" upper_limit="52.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Had a Successful Neurologic Exams Between Intervention and Placebo Group as Determined by a Neurosurgical Provider by Answering Either Yes or No</title>
        <description>Successful neurologic exams are performed by neurosurgical team during the first 24 hour period. Successful neurologic exams will be provided by a neurosurgical professional and they will answer Yes or No if the exam is appropriate.</description>
        <time_frame>from 0 to estimated maximum of 24 hours after surgery</time_frame>
        <population>As length of stay increased in ICU, the likelihood of discharge increased for the patients. This lowered the total amount of analyzed patients as the time increased.</population>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>Subjects will receive 1000mg of intravenous acetaminophen every 6 hours for 24 hours beginning with dural closure.&#xD;
Acetaminophen</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects will receive 100cc of normal saline every 6 hours for 24 hours beginning at dural closure.&#xD;
Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Had a Successful Neurologic Exams Between Intervention and Placebo Group as Determined by a Neurosurgical Provider by Answering Either Yes or No</title>
          <description>Successful neurologic exams are performed by neurosurgical team during the first 24 hour period. Successful neurologic exams will be provided by a neurosurgical professional and they will answer Yes or No if the exam is appropriate.</description>
          <population>As length of stay increased in ICU, the likelihood of discharge increased for the patients. This lowered the total amount of analyzed patients as the time increased.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ICU arrival</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="64"/>
                    <count group_id="O2" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                    <measurement group_id="O2" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 Hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="64"/>
                    <count group_id="O2" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63"/>
                    <measurement group_id="O2" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 Hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="63"/>
                    <count group_id="O2" value="62"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60"/>
                    <measurement group_id="O2" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 Hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="58"/>
                    <count group_id="O2" value="58"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Median Difference in Temperature Between Intervention and Placebo Groups</title>
        <description>Temperature measure in degrees celcius during the first 24hours postoperatively in increments of 8 hours.</description>
        <time_frame>from 0 to estimated maximum 24 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>Subjects will receive 1000mg of intravenous acetaminophen every 6 hours for 24 hours beginning with dural closure.&#xD;
Acetaminophen</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects will receive 100cc of normal saline every 6 hours for 24 hours beginning at dural closure.&#xD;
Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Median Difference in Temperature Between Intervention and Placebo Groups</title>
          <description>Temperature measure in degrees celcius during the first 24hours postoperatively in increments of 8 hours.</description>
          <units>Degrees Celcius</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ICU Arrival</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.6" lower_limit="36.4" upper_limit="36.8"/>
                    <measurement group_id="O2" value="36.7" lower_limit="36.4" upper_limit="36.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.7" lower_limit="36.5" upper_limit="36.9"/>
                    <measurement group_id="O2" value="36.8" lower_limit="36.6" upper_limit="37.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.7" lower_limit="36.5" upper_limit="37.0"/>
                    <measurement group_id="O2" value="36.8" lower_limit="36.6" upper_limit="37.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.8" lower_limit="36.6" upper_limit="37.0"/>
                    <measurement group_id="O2" value="36.7" lower_limit="36.5" upper_limit="37.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sedation Scores Measured by Richmand-Agitation-Sedation Scale (RASS) Every 8 Hours for 24 Hours in Both Groups</title>
        <description>Sedation scores will be evaluated by providers through the Richmand-Agitation-Sedation Scale (RASS) system every 8 hours for the first 24hour postoperatively. The RASS is a 10 point scale with four levels for anxiety or agitation (+1 to +4 (indicates more agitation and alertness the higher number you have)), one level to indicate a calm and alert state (0), and 5 levels of deeper sedation (-1 to -5 ( the more negative number indicating a deeper level of sedation)) patients. It helps guide sedation therapy at the bedside. There are no worse outcomes with different levels of sedation scores. However, typically, we try to keep the scores in the range of 0-+1 to be able to appropriately assess patients and allow them to be mobile in a safe fashion.</description>
        <time_frame>during first 24 hours after surgery</time_frame>
        <population>The amount of participants analyzed decreased as length of stay in the ICU increased as patients were likely discharged from the ICU. The median number indicates the RASS score and not the number of participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>Subjects will receive 1000mg of intravenous acetaminophen every 6 hours for 24 hours beginning with dural closure.&#xD;
Acetaminophen</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects will receive 100cc of normal saline every 6 hours for 24 hours beginning at dural closure.&#xD;
Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Sedation Scores Measured by Richmand-Agitation-Sedation Scale (RASS) Every 8 Hours for 24 Hours in Both Groups</title>
          <description>Sedation scores will be evaluated by providers through the Richmand-Agitation-Sedation Scale (RASS) system every 8 hours for the first 24hour postoperatively. The RASS is a 10 point scale with four levels for anxiety or agitation (+1 to +4 (indicates more agitation and alertness the higher number you have)), one level to indicate a calm and alert state (0), and 5 levels of deeper sedation (-1 to -5 ( the more negative number indicating a deeper level of sedation)) patients. It helps guide sedation therapy at the bedside. There are no worse outcomes with different levels of sedation scores. However, typically, we try to keep the scores in the range of 0-+1 to be able to appropriately assess patients and allow them to be mobile in a safe fashion.</description>
          <population>The amount of participants analyzed decreased as length of stay in the ICU increased as patients were likely discharged from the ICU. The median number indicates the RASS score and not the number of participants.</population>
          <units>median of RASS scores</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ICU arrival</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="66"/>
                    <count group_id="O2" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="-1" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="-1" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="63"/>
                    <count group_id="O2" value="64"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="62"/>
                    <count group_id="O2" value="63"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="57"/>
                    <count group_id="O2" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain VAS Scores (1-100) Every 8 Hours for 24 Hours in Both Groups</title>
        <description>Pain was measured using the Visual Analog Scale (VAS) for each patient at the time of arrival and every eight hours after arrival for the first 24 hours of ICU stay. A VAS score of 1 indicates little or no pain and a VAS score of 100 indicates severe pain.</description>
        <time_frame>during first 24 hours after surgery</time_frame>
        <population>The median number below indicates the median VAS score.</population>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>Subjects will receive 1000mg of intravenous acetaminophen every 6 hours for 24 hours beginning with dural closure.&#xD;
Acetaminophen</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects will receive 100cc of normal saline every 6 hours for 24 hours beginning at dural closure.&#xD;
Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Pain VAS Scores (1-100) Every 8 Hours for 24 Hours in Both Groups</title>
          <description>Pain was measured using the Visual Analog Scale (VAS) for each patient at the time of arrival and every eight hours after arrival for the first 24 hours of ICU stay. A VAS score of 1 indicates little or no pain and a VAS score of 100 indicates severe pain.</description>
          <population>The median number below indicates the median VAS score.</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ICU Arrival</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35" lower_limit="20" upper_limit="60"/>
                    <measurement group_id="O2" value="50" lower_limit="10" upper_limit="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" lower_limit="10" upper_limit="50"/>
                    <measurement group_id="O2" value="45" lower_limit="20" upper_limit="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" lower_limit="10" upper_limit="50"/>
                    <measurement group_id="O2" value="30" lower_limit="10" upper_limit="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" lower_limit="10" upper_limit="50"/>
                    <measurement group_id="O2" value="20" lower_limit="10" upper_limit="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title># of Participants With Delirium Measured by a Positive CAM-ICU Every 8 Hours for 24 Hours in Both Groups-</title>
        <description>Delirium was assessed in each of the participants upon arrival to the ICU using the Confusion Assessment Method for the ICU (CAM-ICU). The CAM-ICU was performed for each participant every 8 hours following admission for the first 24 hours&#xD;
The CAM ICU scoring is based on a scale of 0-7, 0-2=no delirium, 3-5=miild delirium, 6-7=severe delirium. The positive CAM ICU consists of features 1 and 2 and either 3 or 4:&#xD;
Features 1: Acute onset or fluctuating course Features 2: Inattention Features 3: Disorganized thinking Features 4: Altered level of consciousness</description>
        <time_frame>during first 24 hours after surgery</time_frame>
        <population>As the time post surgery increased, the amount of individual participants discharged from the ICU increased.</population>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>Subjects will receive 1000mg of intravenous acetaminophen every 6 hours for 24 hours beginning with dural closure.&#xD;
Acetaminophen</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects will receive 100cc of normal saline every 6 hours for 24 hours beginning at dural closure.&#xD;
Placebo</description>
          </group>
        </group_list>
        <measure>
          <title># of Participants With Delirium Measured by a Positive CAM-ICU Every 8 Hours for 24 Hours in Both Groups-</title>
          <description>Delirium was assessed in each of the participants upon arrival to the ICU using the Confusion Assessment Method for the ICU (CAM-ICU). The CAM-ICU was performed for each participant every 8 hours following admission for the first 24 hours&#xD;
The CAM ICU scoring is based on a scale of 0-7, 0-2=no delirium, 3-5=miild delirium, 6-7=severe delirium. The positive CAM ICU consists of features 1 and 2 and either 3 or 4:&#xD;
Features 1: Acute onset or fluctuating course Features 2: Inattention Features 3: Disorganized thinking Features 4: Altered level of consciousness</description>
          <population>As the time post surgery increased, the amount of individual participants discharged from the ICU increased.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ICU Arrival</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="64"/>
                    <count group_id="O2" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 Hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="65"/>
                    <count group_id="O2" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 Hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="64"/>
                    <count group_id="O2" value="64"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 Hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="59"/>
                    <count group_id="O2" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Median Satisfaction Scores on a Verbal Score From 1(Not Satisfied at All) to 100 (Very Satisfied)</title>
        <description>on a verbal score 1-100, 1 would mean that the patient is not satisfied at all and 100 would mean that the patient was very satisfied.</description>
        <time_frame>During first 24 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>Subjects will receive 1000mg of intravenous acetaminophen every 6 hours for 24 hours beginning with dural closure.&#xD;
Acetaminophen</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Subjects will receive 100cc of normal saline every 6 hours for 24 hours beginning at dural closure.&#xD;
Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Median Satisfaction Scores on a Verbal Score From 1(Not Satisfied at All) to 100 (Very Satisfied)</title>
          <description>on a verbal score 1-100, 1 would mean that the patient is not satisfied at all and 100 would mean that the patient was very satisfied.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.5" lower_limit="55" upper_limit="100"/>
                    <measurement group_id="O2" value="80" lower_limit="50" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Any adverse events were noted for 7 days following completion of the procedure.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Acetaminophen</title>
          <description>Subjects will receive 1000mg of intravenous acetaminophen every 6 hours for 24 hours beginning with dural closure.&#xD;
Acetaminophen</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Subjects will receive 100cc of normal saline every 6 hours for 24 hours beginning at dural closure.&#xD;
Placebo</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="65"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="65"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="65"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Underpowered.&#xD;
Nurses used the local standard order sets.&#xD;
Dexamethasone dose was not standardized&#xD;
Long acting opioids or NSAIDS of any type were not administered.&#xD;
Patients observed every 8 hours for 24 hours postoperatively.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Steven Greenberg</name_or_title>
      <organization>Northshore University Healthsystem, Evanston Hospital</organization>
      <phone>8475702760</phone>
      <email>sbgreenb@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

